$0.1138
-0.0068-5.64%
Last update: Oct 30, 7:31 PM
Vivos Therapeutics Inc (VVOS) Stock Price, Quote, News & History
VVOSNASDAQ
3M shares rose 4.4% premarket after expanding its Amazon data-center deal, including a $521.4M stock warrant; other stocks saw sharp moves.
You can purchase shares of Vivos Therapeutics (NASDAQ:VVOS) through any online brokerage.
Other companies in Vivos Therapeutics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
Vivos Therapeutics has a consensus price target of $3.87.
The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $0.1145 last updated October 30, 2026 at 7:31 PM EDT.
There are no upcoming dividends for Vivos Therapeutics.
Vivos Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Vivos Therapeutics.
Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing...
